Quadrature Capital Ltd Raises Stock Position in HCA Healthcare, Inc. $HCA

Quadrature Capital Ltd grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 977.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 200,999 shares of the company’s stock after buying an additional 182,339 shares during the quarter. HCA Healthcare accounts for approximately 1.0% of Quadrature Capital Ltd’s holdings, making the stock its 26th biggest holding. Quadrature Capital Ltd owned approximately 0.09% of HCA Healthcare worth $85,674,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Sovran Advisors LLC boosted its holdings in shares of HCA Healthcare by 1.0% in the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares during the period. Centerpoint Advisors LLC boosted its stake in HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after buying an additional 22 shares during the period. Cary Street Partners Financial LLC raised its stake in shares of HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the period. Angeles Wealth Management LLC boosted its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock worth $432,000 after purchasing an additional 24 shares during the period. Finally, Hemington Wealth Management raised its position in HCA Healthcare by 11.0% in the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock worth $107,000 after purchasing an additional 25 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price objective on HCA Healthcare in a report on Monday, February 9th. KeyCorp set a $503.00 target price on HCA Healthcare in a research report on Wednesday, January 28th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Finally, The Goldman Sachs Group boosted their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $537.73.

HCA Healthcare Stock Performance

NYSE HCA opened at $531.62 on Friday. The firm’s 50 day moving average price is $505.79 and its 200-day moving average price is $468.65. The company has a market cap of $118.88 billion, a PE ratio of 18.73, a P/E/G ratio of 1.65 and a beta of 1.34. HCA Healthcare, Inc. has a 52-week low of $311.26 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.15%.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last quarter. 1.30% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.